Acceptability of multiple micronutrient powders and iron syrup in Bihar, India

Melissa F Young1,2, Amy Webb Girard1,2, Rukshan Mehta1,2

  • 1Doctoral Program in Nutrition and Health Sciences, Laney Graduate School, Emory University, Atlanta, Georgia, USA.

Insights

Iron and folic acid syrup (IFAS) and multiple micronutrient powders (MNPs) showed high acceptability for preventing childhood anemia in Bihar. Direct IFAS administration ensured full dosage, unlike MNPs which depend on food intake.

Area of Science:

  • Public Health Nutrition
  • Maternal and Child Health
  • Micronutrient Interventions

Background:

  • Childhood anemia is highly prevalent in Bihar, India, affecting nearly two-thirds of young children.
  • Iron and folic acid syrup (IFAS) and multiple micronutrient powders (MNPs) are established interventions for anemia prevention.
  • Assessing the acceptability and preference of these interventions is crucial for effective implementation.

Purpose of the Study:

  • To compare the acceptability and preference of pediatric iron and folic acid syrup (IFAS) versus multiple micronutrient powders (MNPs) in children aged 6-23 months.
  • To evaluate adherence, perceived benefits, side effects, and ease of use for both IFAS and MNPs.
  • To gather insights from mothers and frontline health workers on the practical aspects of administering these supplements.

Main Methods:

  • A randomized crossover trial was conducted in Bihar, India, involving 100 children aged 6-23 months.
  • Participants received either IFAS twice weekly or MNPs for one month, followed by the alternative intervention for another month.
  • Data collection included household surveys, focus group discussions with health workers, and in-depth interviews with mothers.

Main Results:

  • Both IFAS and MNPs demonstrated high adherence and acceptability, exceeding 80%.
  • No significant differences were found in perceived benefits, side effects, or child/maternal preferences between IFAS and MNPs.
  • Mothers and health workers noted that direct IFAS administration ensured full dosage, while MNP intake was dependent on food consumption.

Conclusions:

  • Both IFAS and MNPs are highly acceptable and feasible interventions for preventing childhood anemia in Bihar.
  • Direct administration of IFAS may ensure better compliance compared to MNPs, particularly for younger children.
  • Integrating supplementation strategies with promotion of optimal child feeding practices is essential for maximizing the impact of micronutrient interventions.

Related Concept Videos

Bioavailability Enhancement: Drug Solubility Enhancement01:16

Bioavailability Enhancement: Drug Solubility Enhancement

Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
278
Bioavailability: Overview01:13

Bioavailability: Overview

Bioavailability refers to the proportion of an unaltered drug that, after administration, enters the systemic circulation and can be distributed to the desired action site. Factors such as gastrointestinal (GI) absorption and liver biotransformation influence the bioavailability of a drug when it is administered orally. When a drug is administered intravenously, it enters the systemic circulation directly; by definition, its bioavailability is assumed to be 100%. The bioavailability of an...
4.6K
Modified-Release Drug Delivery Systems: Bioavailability01:30

Modified-Release Drug Delivery Systems: Bioavailability

Modified-release (MR) dosage forms are designed to extend drug release over time, thereby maintaining stable plasma concentrations and reducing dosing frequency. However, their bioavailability is typically below 100% due to incomplete drug release and presystemic metabolism, and limitations in drug permeability across the gastrointestinal epithelium, all of which can restrict the fraction of the drug reaching systemic circulation. Consequently, studying the in vivo bioavailability of MR...
20
Bioavailability Study Design: Single Versus Multiple Dose Studies01:11

Bioavailability Study Design: Single Versus Multiple Dose Studies

Bioavailability studies are essential for understanding how a drug is absorbed, distributed, metabolized, and excreted in the body. These studies assess the extent and rate at which the active pharmaceutical agent becomes available at the site of action. The design of bioavailability studies can involve single-dose or multiple-dose regimens, each with distinct advantages and limitations.Single-dose studies are the preferred approach due to their simplicity and reduced drug exposure for...
255
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
291
Bioequivalence: Overview01:16

Bioequivalence: Overview

Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
2.0K